Matches in Nanopublications for { ?s ?p "DDI between Risperidone and Paliperidone - Paliperidone is the active metabolite of risperidone, 9-OH-risperidone. Concomitant therapy may increase the adverse effects of paliperidone due to additive paliperidone exposure. Consider alternate therapy. [drugbank_resource:DB00734_DB01267]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00734_DB01267 label "DDI between Risperidone and Paliperidone - Paliperidone is the active metabolite of risperidone, 9-OH-risperidone. Concomitant therapy may increase the adverse effects of paliperidone due to additive paliperidone exposure. Consider alternate therapy. [drugbank_resource:DB00734_DB01267]" assertion.